ArticleInvestigational new drugs2023

Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.

Ting Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.